Neonatal hyperbilirubinemia. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: control group:serum bilirubin measurement with HPLC method. Intervention 2: intervention group 1: transcutaneous bilirubin measurement with transcutaneous measurement device. Intervent
Diagnosis
control group:serum bilirubin measurement with HPLC method
intervention group 1: transcutaneous bilirubin measurement with transcutaneous measurement device
intervention group 2:capillary bilirubin measurement with capillary measurement device
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Term neonates. Exclusion criteria: Neonates with sepsis or hemolysis.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum bilirubin measurement. Timepoint: at the time of study. Method of measurement: bilirubin measurement with 3 different methods. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMirhadi Mussavi
Ilam University of Medical Sciences
Outcome results
None listed